Evidence map›Paper›PMID 35080706›Full record

ArticlePharmaceutical research2022

Testing Precision Limits of Neural Network-Based Quality Control Metrics in High-Throughput Digital Microscopy.

Christopher P Calderon, Dean C Ripple, Charudharshini Srinivasan, Youlong Ma, Michael J Carrier, Theodore W Randolph, Thomas F O'Connor

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher P CalderonUrsa Analytics, Inc., Denver, CO, 80212, USA. Chris.Calderon@UrsaAnalytics.com.ORCID http://orcid.org/0000-0001-8024-9081
Dean C RippleBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD, 20899, USA.
Charudharshini SrinivasanDivision of Product Quality Research, Office of Testing and Research, OPQ, CDER, FDA, MD, 20993, USA.
Youlong MaDivision of Product Quality Research, Office of Testing and Research, OPQ, CDER, FDA, MD, 20993, USA.
Michael J CarrierBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD, 20899, USA.
Theodore W RandolphDepartment of Chemical and Biological Engineering, University of Colorado Boulder, CO, 80303, Boulder, USA.
Thomas F O'ConnorDivision of Product Quality Research, Office of Testing and Research, OPQ, CDER, FDA, MD, 20993, USA.

Funding

Quantitative Biotherapeutic Particle Characterization via Deep Neural NetworksR41GM130513 · NIGMS · URSA ANALYTICS, INC. · PI CALDERON, CHRISTOPHER PETER, RANDOLPH, THEODORE W · 2018 to 2018
$222k
NIH HHS R41GM130513SentrySciences LLC NAU.S. Food and Drug Administration PO 75F40120P00203
6 · The paper itself

Abstract

objectiveDigital microscopy is used to monitor particulates such as protein aggregates within biopharmaceutical products. The images that result encode a wealth of information that is underutilized in pharmaceutical process monitoring. For example, images of particles in protein drug products typically are analyzed only to obtain particle counts and size distributions, even though the images also reflect particle characteristics such as shape and refractive index. Multiple groups have demonstrated that convolutional neural networks (CNNs) can extract information from images of protein aggregates allowing assignment of the likely stress at the "root-cause" of aggregation. A practical limitation of previous CNN-based approaches is that the potential aggregation-inducing stresses must be known a priori, disallowing identification of particles produced by unknown stresses.

methodsWe demonstrate an expanded CNN analysis of flow imaging microscopy (FIM) images incorporating judiciously chosen particle standards within a recently proposed "fingerprinting algorithm" (Biotechnol. & Bioeng. (2020) 117:3322) that allows detection of particles formed by unknown root-causes. We focus on ethylene tetrafluoroethylene (ETFE) microparticles as standard surrogates for protein aggregates. We quantify the sensitivity of the new algorithm to experimental parameters such as microscope focus and solution refractive index changes, and explore how FIM sample noise affects statistical testing procedures. RESULTS &

conclusionsApplied to real-world microscopy images of protein aggregates, the algorithm reproducibly detects complex, distinguishing "textural features" of particles that are not easily described by standard morphological measurements. This offers promise for quality control applications and for detecting shifts in protein aggregate populations due to stresses resulting from unknown process upsets.

Indexed as

High-Throughput Screening AssaysImage Processing, Computer-AssistedMicroscopyNeural Networks, ComputerDrug CompoundingProtein AggregatesProteinsReproducibility of ResultsProtein AggregatesProteinsArtificial intelligence analysisConvolutional Neural Networks (CNNs)Digital microscopyFlow Imaging Microscopy (FIM)Protein surrogatesProtein therapeuticsQuality controlStatistical diagnostics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.